The present invention provides an orally disintegratingpowder comprising cilostazol as an active ingredient andmannitol in an amount of 70% by weight or more, which can betaken without water and can be disintegrated in the oralcavity. Saidpowder is suitable for patients to whomcilostazol is administered, especially for aged patients andpatients suffering from dysphagia.